GENECAST's ADPS EGFR Mutation Test Kit used for this clinical study
GENECAST begins clinical research on early diagnosis of lung cancer with Samsung Medical Center
June 14, 2021 05:59 ET | GENECAST
Will it be possible to administer EGFR inhibitors to patients with early-stage non-small cell lung cancer (NSCLC)?The real possibility of the commercial use of liquid biopsies for patients with stage...